Collegium Pharmaceutical, Inc financial data

Symbol
COLL on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Technology Center Drive, Stoughton, MA
State of incorporation
VA
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 105 % -11.7%
Quick Ratio 7.07 % -0.14%
Debt-to-equity 506 % -4.35%
Return On Equity 30.7 % +20.3%
Return On Assets 5.06 % +24.9%
Operating Margin 26.9 % -8.66%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31.5M shares -1.48%
Common Stock, Shares, Outstanding 31.4M shares -1.34%
Entity Public Float 1.03B USD +39.2%
Common Stock, Value, Issued 40K USD +5.26%
Weighted Average Number of Shares Outstanding, Basic 32.1M shares -0.69%
Weighted Average Number of Shares Outstanding, Diluted 40.1M shares -2.84%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 631M USD +11.4%
Operating Income (Loss) 170M USD +1.76%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 98.6M USD +30.2%
Income Tax Expense (Benefit) 29.4M USD +6.53%
Net Income (Loss) Attributable to Parent 69.2M USD +43.7%
Earnings Per Share, Basic 2.14 USD/shares +45.6%
Earnings Per Share, Diluted 1.86 USD/shares +57.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 70.6M USD -70.5%
Marketable Securities, Current 92.2M USD +28.8%
Accounts Receivable, after Allowance for Credit Loss, Current 229M USD +27.3%
Inventory, Net 35.6M USD +9.98%
Other Assets, Current 2.74M USD +2848%
Assets, Current 482M USD -10.3%
Deferred Income Tax Assets, Net 98M USD +273%
Property, Plant and Equipment, Net 14.3M USD -10.3%
Operating Lease, Right-of-Use Asset 5.82M USD -3.43%
Intangible Assets, Net (Excluding Goodwill) 891M USD +111%
Goodwill 162M USD +21.3%
Other Assets, Noncurrent 8.37M USD +914%
Assets 1.66B USD +45.5%
Accounts Payable, Current 3.93M USD -54.7%
Employee-related Liabilities, Current 4.59M USD +204%
Accrued Liabilities, Current 72.1M USD +92%
Liabilities, Current 510M USD +11.3%
Contract with Customer, Liability, Noncurrent 10M USD
Deferred Income Tax Liabilities, Net 54.2M USD -23.9%
Operating Lease, Liability, Noncurrent 5.54M USD -9.55%
Liabilities 1.43B USD +51.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 55K USD +293%
Retained Earnings (Accumulated Deficit) -164M USD +29.7%
Stockholders' Equity Attributable to Parent 229M USD +17.1%
Liabilities and Equity 1.66B USD +45.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 61.9M USD +124%
Net Cash Provided by (Used in) Financing Activities -54.1M USD -179%
Net Cash Provided by (Used in) Investing Activities -18.1M USD -10200%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 39.6M shares +3.81%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 96.6M USD -59.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 17.5M USD -10.4%
Deferred Tax Assets, Valuation Allowance 6.5M USD +12.4%
Deferred Tax Assets, Gross 159M USD +53.8%
Operating Lease, Liability 6.81M USD -4.25%
Depreciation 917K USD +12.2%
Payments to Acquire Property, Plant, and Equipment 568K USD +223%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 69.2M USD +43.7%
Lessee, Operating Lease, Liability, to be Paid 7.9M USD -6.96%
Property, Plant and Equipment, Gross 27.9M USD +8.58%
Operating Lease, Liability, Current 1.27M USD +28.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.73M USD +20.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.68M USD +20.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) -4.41M USD -9491%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.09M USD -20.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.75M USD +18.7%
Deferred Tax Assets, Operating Loss Carryforwards 26.6M USD -21.3%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 11.3M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.57M USD +5.57%
Additional Paid in Capital 590M USD +4.29%
Amortization of Intangible Assets 40.8M USD +12.3%
Deferred Tax Assets, Net of Valuation Allowance 152M USD +56.2%
Share-based Payment Arrangement, Expense 32.4M USD +19.4%
Interest Expense 79.3M USD +0.56%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%